Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Profound Medical (PROF) Net Income towards Common Stockholders (2024 - 2025)

Profound Medical (PROF) has 2 years of Net Income towards Common Stockholders data on record, last reported at $77.0 million in Q4 2025.

  • For Q4 2025, Net Income towards Common Stockholders rose 51.85% year-over-year to $77.0 million; the TTM value through Dec 2025 reached $42.6 million, up 53.04%, while the annual FY2025 figure was $42.6 million, 53.04% up from the prior year.
  • Net Income towards Common Stockholders reached $77.0 million in Q4 2025 per PROF's latest filing, up from -$8.0 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $77.0 million in Q4 2025 and bottomed at -$15.7 million in Q2 2025.